The day before the Canadian government hopes to clinch its Comprehensive Economic and
Trade Agreement (CETA) with Europe at the Sept. 25 summit, opinion remains sharply …

On a per capita basis, Canadian drug costs are already the second highest in the world after
the United States and are among the fastest rising in the Organization for Economic Co …

In a recent article, Morgan and Persaud criticize Canada's drug plan managers for a recent
extension of a generic drug pricing agreement. 1 They explain that New Zealand has lower …

Efforts by Canada's pharmaceutical price review board to lower drug costs have been
largely halted following the resignations of several board members amid allegations that the …

There is no doubt that completion of negotiations for the Comprehensive Economic Trade
Agreement (CETA), announced in October, is a major economic milestone for Canada …

For much of the last decade, Canadian federal health pol-icy has been conspicuous by its
absence. During that time, the federal government has walked away from collaborating with …

Why US Medicare Drug Price Assessments And Negotiations Should Not Use Canada As A
Model | Health Affairs For Authors Products & Access Free Newsletters Subscribe Renew Cart …

In his recent CMAJ commentary, Amir Attaran significantly downplayed the importance of
exceptions in patent law that permit generic drug production. 1 It is misleading to talk about …

" One of the ways of addressing the causes [of high US prices] is to get the other countries of
the world to help bear part of the burden of the R&D," said Senator Jon Kyl, who lobbied …

The process of obtaining authorization to market a new medicine in Canada is similar to that
in other industrialized countries. However, new medicines are approved in Canada later …